...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Otolaryngology--head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery >OK-432 sclerotherapy in head and neck lymphangiomas: long-term follow-up result.
【24h】

OK-432 sclerotherapy in head and neck lymphangiomas: long-term follow-up result.

机译：OK-432头颈部淋巴管瘤硬化疗法：长期随访结果。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

INTRODUCTION: Nonsurgical treatments, such as sclerotherapy have been attempted for head and neck lymphagiomas. Of the available sclerosing agents, picibanil has shown satisfactory short-term treatment results in many studies, but no study has presented long-term treatment results. Accordingly, in the present study, the authors retrospectively reviewed the long-term treatment results of picibanil sclerotherapy. MATERIALS AND METHODS: Fifty-five lymphangioma patients who underwent picibanil sclerotherapy were enrolled. Data about initial and long-term response, recurrence, and excision rate were collected. RESULTS: Initial response rates were 83.5 percent and long-term response rates were 76.3 percent. CONCLUSION: Initial and the long-term response rate were equally good for lymphangioma.
机译：引言：头颈部淋巴管瘤已尝试非手术治疗，例如硬化疗法。在许多可用的硬化剂中，picibanil在许多研究中均显示出令人满意的短期治疗效果，但尚无研究显示长期治疗效果。因此，在本研究中，作者回顾性回顾了皮比巴尼硬化疗法的长期治疗结果。材料与方法：纳入了接受picibanil硬化疗法的55例淋巴管瘤患者。收集有关初始和长期反应，复发和切除率的数据。结果：初始缓解率为83.5％，长期缓解率为76.3％。结论：淋巴管瘤的初始和长期应答率均相同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号